News

Chlamydia more prevalent in men than in women

26-Mar-07

Practices should test more men for chlamydia, according to a major UK report on STIs.

The main focus of the national chlamydia screening programme in England is on women aged 16-24 who attend contraceptive clinics.

But research commissioned by the Health Technology Assessment programme has found that chlamydia prevalence in asymptomatic young men is the same as in women, suggesting that as many young men should be screened for chlamydia as women.

The study of over 4,500 patients identified 219 positive cases of chlamydia. Prevalence of chlamydia was found to be higher in men aged 20-24, 6.9 per cent, than in women of the same age group, 6.2 per cent.

Comments

Only registered users may comment. Log in now or register for a free account.

Login to comment


forgotten your password?

Healthcare Republic Forums

 

Registrar

nMRCGP exam update - Evidence for aspirin use

Current situation. Read more

RCGP curriculum - Introducing the GP curriculum

Dr Ben Riley and Dr Jayne Haynes explain what the curriculum is and why it is necessary. Read more

Alcohol problems in young people

Greater awareness of drinking problems is needed, say Professor Eileen Kaner and Ruth McGovern. Read more

Show all articles

 

Latest Clinical Articles

Altitude-related illness

Contributed by Dr Matthew Litchfield, GP, Nottingham and Dr James Milledge, retired consultant respi... Read more

Clinical Review - Subfertility in women

Contributed by Mr David Walker, consultant obstetrician and gynaecologist at the Royal United Hospit... Read more

Stable angina pectoris

Contributed by Dr Unni Krishnan, clinical research fellow in cardiology at the Glenfield Hospital, L... Read more

Show all clinical articles

MIMS Product News

New drug - Volibris

GSK has launched Volibris (ambrisentan) for the treatment of pulmonary arterial hypertension (WHO Cl... Read more

New drug - Thymoglobuline

Thymoglobuline is an immunosuppressant for the prophylaxis of graft rejection in renal or heart tra... Read more

New drug - Tyverb

Tyverb (lapatinib) is an oral antineoplastic agent that may provide women with an alternative option... Read more

Jobs

 

Job of the Week